Startup · $9.6m raised · AI
startup building AI-designed personalized mRNA cancer vaccines for dogs
Sydney, NSW
Programs: Y Combinator (Summer 2026 batch)
Every investor coverage indicates participated in a round Gamgee raised.
| Investor | Rounds | Invested |
|---|---|---|
| Y Combinator | Seed · Seed · Accelerator | - |
| Steve Eidelman | Seed | - |
| Gokul Rajaram | Seed · Seed | - |
| Founders Fund | Seed · Seed | - |
| Celine Halioua | Seed · Seed | - |
| Celine Halioua | Seed | - |
| Arash Ferdowsi | Seed · Seed | - |
| Angel Investors | Seed | - |
Companies Gamgee acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Paul Conyngham | CEO · Founder | trysignalbase.com, kucoin.com, newshub.medianet.com.au, theunderbite.co |
Stories naming Gamgee. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Dog cancer vaccine startup Gamgee has raised $4 million in seed funding led by Founders Fund with Y Combinator, to speed clinical trials and product development for its AI-personalised canine vaccines.
Also trysignalbase.com
Weekly roundup: Constantinople raises $62.5m; Blackbird wraps fund six above $1b; Guardhouse buys Mobohubb; SCX.ai debuts on the ASX; plus seed rounds, exits and executive changes across the ecosystem.
Veterinary biotech Gamgee has raised a four million dollar seed round led by Founders Fund, launching from Y Combinator to develop personalised mRNA cancer vaccines for dogs.
Also newshub.medianet.com.au·Dealroom·thesaasnews.com·kucoin.com